Analogs of the incretin hormones glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP) have become mainstays of obesity and diabetes management. Here, GIP is linked to obesity due to melanocortin 4 receptor deficiency.